Literature DB >> 18974559

Myotubular/centronuclear myopathy and central core disease.

Chieko Fujimura-Kiyono1, Gabor Z Racz, Ichizo Nishino.   

Abstract

The term congenital myopathy is applied to muscle disorders presenting with generalized muscle weakness and hypotonia from early infancy with delayed developmental milestones. The congenital myopathies have been classified into various categories based on morphological findings on muscle biopsy. Although the clinical symptoms may seem homogenous, the genetic basis is remarkably variable. This review will focus on myotubular myopathy, centronuclear myopathy, central core disease, and congenital neuromuscular disease with uniform Type 1 fiber, myopathies that are subjects of our ongoing examinations.

Entities:  

Mesh:

Year:  2008        PMID: 18974559     DOI: 10.4103/0028-3886.43451

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  4 in total

1.  Mutation studies in X-linked myotubular myopathy in three Indian families.

Authors:  Sunita Bijarnia; Ratna D Puri; Monika Jain; Neelam Kler; Subimal Roy; J Andoni Urtizberea; Valerie Biancalana; I C Verma
Journal:  Indian J Pediatr       Date:  2010-03-31       Impact factor: 1.967

2.  X-linked recessive myotubular myopathy with MTM1 mutations.

Authors:  Young-Mi Han; Kyoung-Ah Kwon; Yun-Jin Lee; Sang-Ook Nam; Kyung-Hee Park; Shin-Yun Byun; Gu-Hwan Kim; Han-Wook Yoo
Journal:  Korean J Pediatr       Date:  2013-03-18

3.  Constitutive expression of Yes-associated protein (Yap) in adult skeletal muscle fibres induces muscle atrophy and myopathy.

Authors:  Robert N Judson; Stuart R Gray; Claire Walker; Andrew M Carroll; Cecile Itzstein; Arimantas Lionikas; Peter S Zammit; Cosimo De Bari; Henning Wackerhage
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

4.  Mutations in BIN1 associated with centronuclear myopathy disrupt membrane remodeling by affecting protein density and oligomerization.

Authors:  Tingting Wu; Zheng Shi; Tobias Baumgart
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.